Poland· PL-100171282
Procto-Hemolan protect
A medicinal product containing suppositoria antihaemorrhoidales, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Suppositoria antihaemorrhoidales
- Manufacturer
- Aflofarm Farmacja Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990654871
- gtin05909990654888
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c48ee9b2-e989-431a-9187-905af1517b4c GET /v1/drugs/c48ee9b2-e989-431a-9187-905af1517b4c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Czopki",
"source": "urpl",
"strength": "-",
"packaging": "05909990654871 ¦ OTC ¦ 44652\n10 szt. (1 x 10)\n05909990654888 ¦ OTC ¦ 44653\n10 szt. (2 x 5)",
"substance": "Tanninum 0.15 g + Bismuthi subgallas 0.2 g + Zinci oxidum 0.1 g",
"common_name": "Suppositoria antihaemorrhoidales",
"pl_product_id": "100171282",
"pozwolenie_nr": "14772",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about suppositoria antihaemorrhoidales.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.